Related Experiment Video
Updated: Apr 26, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery
Xinuo Li1, Jinran Li2, Yuan Sun2
1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China; School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.
Proteolysis-targeting chimeras (PROTACs) show promise for neurodegenerative diseases but face blood-brain barrier challenges. Advances in delivery systems and molecular engineering are improving brain penetration for these novel CNS drugs.
Area of Science:
- Neuroscience
- Pharmacology
- Biotechnology
Background:
- Drug development for central nervous system (CNS) disorders, including neurodegenerative diseases (NDs), is challenging.
- Proteolysis-targeting chimeras (PROTACs) offer a novel therapeutic approach but struggle with blood-brain barrier (BBB) permeability and pharmacokinetics.
Purpose of the Study:
- To review recent advances and challenges in CNS-targeted delivery strategies for PROTACs.
- To highlight molecular engineering approaches enhancing PROTAC drug-likeness and BBB transport.
- To discuss future directions for PROTAC development in treating CNS disorders.
Main Methods:
- Review of noninvasive BBB-penetrant delivery systems (viral vectors, exosomes, nanocarriers, biomimetic vehicles).
- Emphasis on intranasal administration for direct brain delivery.
- Analysis of molecular engineering strategies (E3 ligase selection, linker modulation, ligand optimization).
Main Results:
- Diverse delivery strategies are emerging to improve PROTAC brain penetration.
- Molecular engineering enhances PROTAC properties for better CNS exposure.
- Current designs integrate peptides, nanoparticles, and prodrugs to optimize stability, selectivity, and brain exposure.
Conclusions:
- Integrating advanced delivery platforms with rational structural optimization is crucial for enhancing BBB permeability.
- Artificial intelligence and targeted protein degradation offer new pathways for targeting undruggable CNS proteins.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

